The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

In a phase III trial, orforglipron yielded better HbA1c reduction compared with oral semaglutide at 52 weeks. Gastrointestinal side effects were more common with orforglipron, leading to more ...

One of the key scientific challenges of creating this medicine has been the short lifespan of natural GLP-1, which is rapidly broken down in the body within minutes ...

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 available to buy as a daily pill. Wegovy was ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. GLP-1 medications like semaglutide (Ozempic) have a number of ...

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced ...

A phase 2, randomized, double-blind trial (N=50) used oral semaglutide 3 mg/day then 7 mg/day, combining cue-reactivity testing with Timeline Follow-Back naturalistic drinking assessment and objective ...